ARCHIVES

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Questions Raised By Committee Kills Still Not Resolved

July 29, 1977

Letter to the Editor: Colleagues describe Bunn As Leader, Patient Advocate

January 12, 1996

Skipper, Cohen, Burkitt Win GM $100,000 awards, Medal

June 18, 1982

DePinho Will Not Meet With AAUP In Probe of Tenure Denial Dispute

September 19, 2014

Guest Editorial: Richard Schilsky Reflects On His Past Decade WithThe Board of Scientific Advisors

June 24, 2011

New ACS Program Honors Mary Lasker

August 31, 1984